Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC).

被引:0
|
作者
Luen, Stephen James
Salgado, Roberto
Dieci, Maria Vittoria
Vingiani, Andrea
Curigliano, Giuseppe
Hubbard, Rebekah
Altamirano, Carlos Castaneda
Sanchez, Joselyn
D'Alfonso, Timothy
Cheng, Esther
Garcia, Miluska Castillo
Adams, Sylvia
Ahmed, Fahad
Rimm, David L.
Demaria, Sandra
Symmans, William Fraser
Michiels, Stefan
Loi, Sherene
机构
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Inst Jules Bordet, Brussels, Belgium
[3] Univ Padua, Padua, Italy
[4] Ist Oncol Veneto IRCCS, Padua, Italy
[5] Ist Eur Oncol, Milan, Italy
[6] Univ Milan, Ist Eur Oncol, Milan, Italy
[7] Univ Texas MD Anderson Canc Ctr, Div Pathol, Houston, TX 77030 USA
[8] Inst Nacl Enfermedades Neoplas, Lima, Peru
[9] Cornell Univ, New York, NY 10021 USA
[10] NYU, Sch Med, Perlmutter Canc Ctr, New York, NY USA
[11] Yale Univ, New Haven, CT USA
[12] Yale Sch Med, New Haven, CT USA
[13] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY USA
[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[15] Inst Gustave Roussy, Villejuif, France
关键词
D O I
10.1200/JCO.2018.36.15_suppl.571
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
571
引用
收藏
页数:1
相关论文
共 50 条
  • [1] The prognostic role of tumor-infiltrating lymphocytes after treatment with neo-adjuvant chemotherapy in inflammatory breast cancer patients
    Van Berckelaer, Christophe
    Vercauteren, Leonie
    Vermeiren, Iris
    Broeckx, Glenn
    Van Laere, Steven
    Dirix, Luc
    Colpaert, Cecile
    Van Dam, Peter
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [2] Tumor-infiltrating lymphocytes (TILs) for prediction of response to platinum-based neo-adjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC)
    Abdullaeva, Sheyda
    Semiglazova, Tatiana
    Artemyeva, Anna
    Semiglazov, Vladislav
    Krivorotko, Petr
    Semiglazov, Vladimir
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy
    Luen, S. J.
    Salgado, R.
    Dieci, M. V.
    Vingiani, A.
    Curigliano, G.
    Gould, R. E.
    Castaneda, C.
    D'Alfonso, T.
    Sanchez, J.
    Cheng, E.
    Andreopoulou, E.
    Castillo, M.
    Adams, S.
    Demaria, S.
    Symmans, W. F.
    Michiels, S.
    Loi, S.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (02) : 236 - 242
  • [4] Prognostic value of tumor infiltrating lymphocytes (TILs) on residual disease after primary chemotherapy for triple-negative breast cancer (TNBC) patients
    Dieci, M. V.
    Criscitiello, C.
    Guarneri, V.
    Conte, P. F.
    Goubar, A.
    Charpy, C.
    Viale, G.
    Delaloge, S.
    Curigliano, G.
    Andre, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S479 - S480
  • [5] Prognostic and predictive value of tumor-infiltrating lymphocytes (TILs) in triple-negative breast cancers (TNBC) treated with neoadjuvant chemotherapy (NAC)
    Herrero-Vicent, C.
    Guerrero, A.
    Gavila, J.
    Gozalbo, F.
    Blanch, S.
    Hernandez, A.
    Sandiego, S.
    Calatrava, A.
    Guillem, V.
    Ruiz, A.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [6] Artificial intelligence (AI)-powered spatial analysis of tumor-infiltrating lymphocytes (TIL) for prediction of response to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC).
    Lee, Hee Jin
    Cho, Soo Yoon
    Cho, Eun Yoon
    Lim, Yoojoo
    Cho, Soo Ick
    Jung, Wonkyung
    Song, Sanghoon
    Kang, Mingu
    Ryu, Jeongun
    Ma, Minuk
    Park, Seonwook
    Paeng, Kyunghyun
    Ock, Chan-Young
    Song, Sang Yong
    Gong, Gyungyub
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Spatial organization of tumor-infiltrating lymphocytes (TILs) is prognostic for survival in triple negative breast cancer (TNBC)
    Patel, Sahil H.
    Corredor, German
    Yoder, Rachel
    Barrera, Cristian
    Castillo, Miluska
    Bernabe, Luis
    Staley, Joshua
    Stecklein, Shane
    Viswanath, Satish E.
    Castaneda, Carlos A.
    Sharma, Priyanka
    Madabhushi, Anant
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [8] Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study
    Dieci, M. V.
    Criscitiello, C.
    Goubar, A.
    Viale, G.
    Conte, P.
    Guarneri, V.
    Ficarra, G.
    Mathieu, M. C.
    Delaloge, S.
    Curigliano, G.
    Andre, F.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (03) : 611 - 618
  • [9] Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
    Leon-Ferre, Roberto A.
    Polley, Mei-Yin
    Liu, Heshan
    Gilbert, Judith A.
    Cafourek, Victoria
    Hillman, David W.
    Elkhanany, Ahmed
    Akinhanmi, Margaret
    Lilyquist, Jenna
    Thomas, Abigail
    Negron, Vivian
    Boughey, Judy C.
    Liu, Minetta C.
    Ingle, James N.
    Kalari, Krishna R.
    Couch, Fergus J.
    Visscher, Daniel W.
    Goetz, Matthew P.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (01) : 89 - 99
  • [10] Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
    Roberto A. Leon-Ferre
    Mei-Yin Polley
    Heshan Liu
    Judith A. Gilbert
    Victoria Cafourek
    David W. Hillman
    Ahmed Elkhanany
    Margaret Akinhanmi
    Jenna Lilyquist
    Abigail Thomas
    Vivian Negron
    Judy C. Boughey
    Minetta C. Liu
    James N. Ingle
    Krishna R. Kalari
    Fergus J. Couch
    Daniel W. Visscher
    Matthew P. Goetz
    [J]. Breast Cancer Research and Treatment, 2018, 167 : 89 - 99